Cleveland Diagnostics News and Activities

Cleveland Diagnostics is owned by Cleveland Clinic.

Cleveland Clinic is one of the...

• Private Power;
• TOB Iconic 10,000.

Cleveland Clinic has a direct presence in 2 countries.

Cleveland Clinic has 4 subsidiaries including Cleveland Clinic Florida, Cleveland Clinic London and Cleveland Diagnostics.

They are in:

• Healthcare80%
• Biotechnology20%

View the org chart displaying its 26 main executives

Most searched biographies at Cleveland Diagnostics

• Michael Iskra, Chief Executive Officer
• Dara Wrightson, Director
• Joseph Rich, Director

Popular executive movements at Cleveland Diagnostics

• Jack Kenny has joined the company as Chairman of the Board  (posted on February 6 2026).
• Michael Iskra has joined the company as Chief Executive Officer  (posted on February 6 2026).
• Arnon Chait, who was Chief Executive Officer, is promoted to Chief Innovation Officer  (posted on February 6 2026).

Click here to view some more movements at Cleveland Diagnostics

Create your alert
to follow the executive moves at Cleveland Diagnostics.

Cleveland Clinic has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Cleveland Diagnostics

• Cleveland Diagnostics Achieves ISO 13485:2016 Certification, Advancing Commercial Expansion for IsoPSA® IVD Assay
• Cleveland Diagnostics: Michael Iskra, Arnon Chait | 360Dx
• Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
• Michael Iskra Appointed CEO of Cleveland Diagnostics to Drive Strategic & Accelerated Growth Following FDA Approval of Its IsoPSA Assay
• FDA Approves IsoPSA® -- Cleveland Diagnostics’ Novel Blood-Based Prostate Cancer Test
• Cleveland Diagnostics Brings PSA on PSA Campaign Back This September
• Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
• Changing the Prostate Cancer Screening Landscape - MedCity News
• Trendspotting: Predictions for Bio-IT World in 2025
• The 2024 PharmaVoice 100
• View more press releases Close

Social media about Cleveland Diagnostics

• Cleveland Diagnostics on Wikipedia, Google News & Yahoo Finance
• Cleveland Diagnostics on LinkedIn, X (Twitter) & YouTube